. Author manuscript; available in PMC: 2021 Aug 1.

Published in final edited form as: Dig Dis Sci. 2019 Nov 14;65(8):2403–2411. doi: 10.1007/s10620-019-05955-2

Table 5.

Associations of mortality and cancer-related mortality with H. pylori positive gastric cancer compared to H. pylori negative gastric cancer. Hazards ratios (HR) and 95% confidence intervals (CI) reported for univariate and multivariate models, adjusted for age, race, cancer stage, and receipt of treatment.

	Unadjusted HR (95% CI)	Adjusted HR (95% CI)
Overall Mortality
H. pylori positive	0.81 (0.46–1.41)	0.85 (0.45–1.62)
H. pylori positive (including suspected)	0.62 (0.36–1.07)	0.61 (0.33–1.12)
Cancer-related Mortality
H. pylori positive	0.79 (0.44–1.42)	0.86 (0.43–1.73)
H. pylori positive (including suspected)	0.57 (0.32–1.01)	0.56 (0.29–1.07)